Azmacort and Haematuria - a phase IV clinical study of FDA data

Summary:

Haematuria is reported as a side effect among people who take Azmacort (triamcinolone acetonide), especially for people who are male, 30-39 old, also take Levaquin, and have Metastases to bone.

The phase IV clinical study analyzes which people have Haematuria when taking Azmacort. It is created by eHealthMe based on reports of 3,588 people who have side effects when taking Azmacort from the FDA, and is updated regularly.

What is Azmacort?

Azmacort has active ingredients of triamcinolone acetonide. It is often used in asthma. eHealthMe is studying from 3,612 Azmacort users. Check the latest studies of Azmacort.

What is Haematuria?

Haematuria (presence of blood in urine) is found to be associated with 1,705 drugs and 2,519 conditions by eHealthMe. Check the latest studies of Haematuria.

On Jul, 17, 2026

3,588 people reported to have side effects when taking Azmacort.
Among them, 17 people (0.47%) have Haematuria.

Among these 17 people:

What is the gender of people who have Haematuria when taking Azmacort? *

female: 5.88 %
male: 94.12 %

What is the age of people who have Haematuria when taking Azmacort? *

What are other drugs people take besides Azmacort? *

What are other side effects people have besides Haematuria? *

Nosebleed (bleeding from nose): 15 people, 88.24%
Depression: 14 people, 82.35%
Back Pain: 13 people, 76.47%
Insomnia (sleeplessness): 13 people, 76.47%
Nausea (feeling of having an urge to vomit): 13 people, 76.47%
Hypoaesthesia (reduced sense of touch or sensation): 13 people, 76.47%
Stress And Anxiety: 13 people, 76.47%
Pain: 12 people, 70.59%
Injury: 11 people, 64.71%
Groin Pain: 11 people, 64.71%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 10 people, 58.82%
Metastases To Bone (cancer spreads to bone): 10 people, 58.82%
Pain: 4 people, 23.53%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 5.88%
Rashes (redness): 1 person, 5.88%
Insomnia (sleeplessness): 1 person, 5.88%
Gastritis (inflammation of stomach): 1 person, 5.88%
Diabetes: 1 person, 5.88%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 5.88%
Acute Coronary Syndrome (acute chest pain and other symptoms that happen because the heart does not get blood): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Azmacort and have Haematuria?

- Check whether Haematuria is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Azmacort:

Azmacort (3,612 reports)

Haematuria treatments and more:

Haematuria (44,248 reports)

Browse all side effects of Azmacort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Haematuria:

Haematuria (1,705 drugs)

Browse all the conditions that are associated with Haematuria:

Haematuria (2,519 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on triamcinolone acetonide (the active ingredients of Azmacort) and Azmacort (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.